Skip to main content
SpringerLink
Log in

Weiterführende Literatur

  • Chapter
Epilepsie

Part of the book series: Optimierte Arzneimitteltherapie ((ARZNEIMITTELTH.))

  • 187 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 29.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Weiterführende Literatur

  • Alvarez N, Besag F, Livanainen M (1998) Use of antiepileptic drugs in the treatment of epilepsy in people with intellectuel disability. J Int Dis Res 42:1–15

    Article  Google Scholar 

  • Ben-Menachem E et al. (1996) Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 37:539–543

    Article  PubMed  CAS  Google Scholar 

  • Bialer M, Sanjay TW et al. (1999) Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference. Epilepsy Res 34:1–41

    Article  PubMed  CAS  Google Scholar 

  • Browne TR, Kugler AR, Eldon MA (1996) Pharmacology and pharmacokinetics of fosphenytoin. Neurology (Suppl.1) 46:3–7

    Google Scholar 

  • Dannhardt G (1995) Antiepileptika—Pharmakokinetik und therapeutische Anwendung. Pharm Ztg 140:3227–3236

    Google Scholar 

  • Dannhardt G (2000) Epilepsie: Hoffnung für die Patienten durch neue Medikamente. Pharm Ztg 145:11–21

    Google Scholar 

  • Dannhardt G (2000) Epilepsie: Ergänzende und alternative Behandlungsmethoden. Pharm Ztg 145:74

    Google Scholar 

  • Dannhardt G, vonGruchalla M (1997) Der NMDA-Rezeptor und seine Liganden bei cerebraler Ischämie. Pharm Ztg 142:1359–1374

    Google Scholar 

  • Dannhardt G, Kohl BK (1998) The glycine site on the NMDA receptor: Structureactivity relationships and possible therapeutic applications. Curr Med Chem 5:253–263

    PubMed  CAS  Google Scholar 

  • Dannhardt G, Kohl BK (2001) The NMDA Receptor Complex: A promising target for novel antiepileptic strategies. Curr Med Chem 8:1275–1289

    Article  PubMed  Google Scholar 

  • Gasior M, Ungard JT, Witkin JM (1999) Preclinical evaluation of newly approved and potential antiepileptic drugs against cocaine-induced seizures. J Pharmacol Exp Ther 290:1148–1156

    PubMed  CAS  Google Scholar 

  • Gee NS, Sanjay TW et al. (1996) The novel anticonvulsant drug, gabapentin (neurontin) binds to the.?2.?-subunit of a calcium channel. J Biol Chem 271:5768–5776

    Article  PubMed  CAS  Google Scholar 

  • Grant SM, Faulds D (1992) Oxcarbazepine: A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders. Drugs 43:873–888

    Article  PubMed  CAS  Google Scholar 

  • Hagers Handbuch der Pharmazeutischen Praxis (1993) 5. Auflage, Stoffe Bände 7-9, Folgebände 4 und 5, Springer-Verlag, Berlin, Heidelberg, New York

    Google Scholar 

  • Johnson S, Johnson FN (eds.) (1994) Lamotrigine. Rev Contemp Pharmacother 5:67–151

    Google Scholar 

  • Ketter TA, Sanjay TW et al. (1999) Metabolism and excretion of novel stabilizers and new anticonvulsants. Cell Mol Neurobiol 19:511–532

    Google Scholar 

  • Klitgaard H, Sanjay TW et al. (1998) Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur J Pharmacol 353:191–206

    Article  PubMed  CAS  Google Scholar 

  • Leppik IE (1995) Tiagabine: The safety landscape. Epilepsia (Suppl. 6) 36:10–13

    Article  Google Scholar 

  • Löscher W, Schmidt D (1988) Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 2:45–181

    Google Scholar 

  • Mallarkey G, Palmer JK (eds.) (1999) Issues in Epilepsy. Adis International Ltd.

    Google Scholar 

  • Mimaki T (1998) Clinical pharmacology and therapeutic drug monitoring of zonisamide. Ther Drug Monit 20:593–597

    Article  PubMed  CAS  Google Scholar 

  • Mutschler E (1996) Arzneimittelwirkungen 7. Auflage, Wissenschaftliche Verlagsgesellschaft Stuttgart

    Google Scholar 

  • Pellock JM (1999) Felbamate in epilepsy therapy. Drug Safety 225–230.

    Google Scholar 

  • Pinto F, Tassinari CA (eds.) (1996) Topiramate: New Advances in the treatment of epilepsy. Epilepsia (Suppl. 2) 37:1–23

    Google Scholar 

  • Sabers A, Gram L (1992) Pharmacology of Vigabatrin. Pharmacol Toxicol 70:237–243

    Article  PubMed  CAS  Google Scholar 

  • Sofia RD (1995) Felbamate, Mechanisms of action. In: Antiepileptic drugs, 4th edition. Raven Press Ltd. 791–800.

    Google Scholar 

  • Speight TM, Holford NHG (1996) Avery’s Drug Treatments, 4th Edition, Adis International

    Google Scholar 

  • Suzdak PD, Jansen JA (1995) A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor. Epilepsia 316:612–626

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pharmazie, Johannes-Gutenberg-Universität, Staudinger Weg 5, 55099, Mainz, Germany

    Prof. Dr. Gerd Dannhardt

  2. DRK Schmerzzentrum, Auf der Steig 14-16, 55131, Mainz, Germany

    Dr. Susann Seddigh

  3. Klinik und Poliklinik für Neurologie, Reisingerweg, Geb. 701, 55101, Mainz, Germany

    Priv.-Doz. Dr. Thomas Vogt

Authors
  1. Prof. Dr. Gerd Dannhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. Susann Seddigh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Priv.-Doz. Dr. Thomas Vogt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dannhardt, G., Seddigh, S., Vogt, T. (2002). Weiterführende Literatur. In: Epilepsie. Optimierte Arzneimitteltherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56244-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56244-0_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-42440-6

  • Online ISBN: 978-3-642-56244-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation